Trials / Completed
CompletedNCT00626743
Phase I Study to Investigate the Effect on the Blood Pressure After Oral Administration of SK3530 and Amlodipine
Clinical Trial to Investigate the Influence of SK3530 on the Blood Pressure of Patients With Hypertension Taking Amlodipine
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- SK Chemicals Co., Ltd. · Industry
- Sex
- Male
- Age
- 19 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
To assess the pharmacodynamic effects of co-administrated SK3530 (PDE5 inhibitor) and Amlodipine, phase I study in Hypertensive patient was designed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SK3530 100mg, Placebo, Amlodipine |
Timeline
- Start date
- 2008-05-01
- Primary completion
- 2009-05-01
- Completion
- 2011-07-01
- First posted
- 2008-02-29
- Last updated
- 2014-04-21
- Results posted
- 2014-04-21
Locations
2 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00626743. Inclusion in this directory is not an endorsement.